EUVIMEDEUVIMED entdecken
Open Access

Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients

Kamlesh Garg, Perumal Raveendranath, Sameer Gulati, Sufian Zaheer, Amita Yadav, Ruchika Nandha

Bioinformation · 30.06.2026 · 22 (6) · 3768-3772

DOI: 10.6026/973206300223768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 30.06.2026. Verfasst von Kamlesh Garg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Pharmacology, & Biochemistry, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension may adversely affect bone health, but the skeletal effects of commonly prescribed antihypertensive drugs remain inadequately understood. In this 24-week prospective study, 96 newly diagnosed Stage I hypertensive patients received either Amlodipine (5–10 mg) or Telmisartan (40–80 mg), with serial assessment of bone metabolism markers. Both drugs achieved comparable blood pressure control throughout the study period. Telmisartan significantly reduced PTH and IL-6 levels while enhancing BS-ALP and transiently increasing osteocalcin, whereas Amlodipine demonstrated only a temporary rise in BS-ALP. Thus, data shows the telmisartan may provide additional benefits on bone remodeling and skeletal health in hypertensive patients at risk of fragility.

Schlagwörter

Stichwörter der Autor:innen

Bone metabolism markersamlodipinebone turnover markersbone-specific alkaline phosphatasehypertensioninterleukin-6osteocalcinparathormonetelmisartan

Autor:innen und Institutionen

  • Department of Pathology, Pharmacology, & Biochemistry, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
  • Department of Medicine, Lady Hardinge Medical College, New Delhi, India.
  • Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India.

Zitieren

APA

Garg, K., Raveendranath, P., Gulati, S., Zaheer, S., Yadav, A., & Nandha, R. (2026). Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients. Bioinformation, 22(6), 3768-3772. https://doi.org/10.6026/973206300223768

Vancouver

Garg K, Raveendranath P, Gulati S, Zaheer S, Yadav A, Nandha R. Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients. Bioinformation. 2026;22(6):3768-3772. doi:10.6026/973206300223768

BibTeX
@article{Garg2026,
  author = {Garg, Kamlesh and Raveendranath, Perumal and Gulati, Sameer and Zaheer, Sufian and Yadav, Amita and Nandha, Ruchika},
  title = {Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {3768--3772},
  doi = {10.6026/973206300223768}
}
Kostenlos starten →